Effects of Methylxanthine Derivatives on Adriamycin Concentration and Antitumor Activity

por Sadzuka, Yasuyuki, Iwazaki, Ayano, Miyagishima, Atsuo, Nozawa, Yasuo, Hirota, Sadao
Publicado 1995

1‐Methyl‐3‐propyl‐7‐butylxanthine, a Novel Biochemical Modulator, Enhances Therapeutic Efficacy of Adriamycin

por Sadzuka, Yasuyuki, Iwazaki, Ayano, Sugiyama, Tomomi, Sawanishi, Takayuki, Miyamoto, Ken‐ichi
Publicado 1998

Population pharmacokinetics of afatinib and exposure-safety relationships in Japanese patients with EGFR mutation-positive non-small cell lung cancer

por Nakao, Keiko, Kobuchi, Shinji, Marutani, Shuhei, Iwazaki, Ayano, Tamiya, Akihiro, Isa, Shunichi, Okishio, Kyoichi, Kanazu, Masaki, Tamiya, Motohiro, Hirashima, Tomonori, Imai, Kimie, Sakaeda, Toshiyuki, Atagi, Shinji
Publicado 2019